is glp 1 r retatrutide vs. Ozempic RETATRUTIDE: The Triple-Agonist Rewriting Obesity

they are not FDA-approved drugs and require ongoing clinical oversight and patient responsibility

health panels move tremendously frustrating: expert Timothy Caulfield, a health law expert, said the FDA advisory panels decision is tremendously frustrating. I certainly hope that it doesnt influence what Health Canada does

If gastrointestinal symptoms significantly impair quality of life or prevent medication adherence despite conservative management, healthcare providers may consider dose adjustment, alternative agents with potentially different side effect profiles, or referral to a gastroenterologist for specialized evaluation

One particularly noteworthy association that stood out is the significant risk reduction across multiple gastrointestinal cancers, including colorectal, esophageal, stomach, gallbladder, liver and pancreatic cancers, Wang said

LifeMD has integrated with LillyDirects pharmacy to provide patients streamlined access to Founday and other Eli Lilly obesity treatments at pre-negotiated pricing that's often lower than standard retail rates

GLP1 medications slow gastric emptying, and some experts have raised questions around oral medication absorption, including oral HRT